Genetic variation in ST6GAL1 is a determinant of capecitabine and oxaliplatin induced hand-foot syndrome. Watts K, Wills C, Madi A, Palles C, et al. Int J Cancer 2022;151:957-966.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Watts K, Wills C, Madi A, Palles C, et al. Genetic variation in ST6GAL1 is a determinant of capecitabine and oxaliplatin induced hand-foot syndrome. Int J Cancer 2022;151:957-966.
PMID: 35467766